PROCEPT生物机器人

最新新闻

• 评级变动
  Truist Financial Downgrades PROCEPT BioRobotics(PRCT.US) to Hold Rating, Announces Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/7/3
• 评级变动
  William Blair Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/9
• Barclays Initiates PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 评级变动
  Leerink Partners Downgrades PROCEPT BioRobotics(PRCT.US) to Hold Rating, Cuts Target Price to $29
  \u5e02\u573a\u8d44\u8baf · 2026/6/12
• 评级变动
  BofA Securities Maintains PROCEPT BioRobotics(PRCT.US) With Sell Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Evercore Initiates PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Teva Pharmaceutical (TEVA) and PROCEPT BioRobotics (PRCT)
  TipRanks · 2026/4/30
• A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $21 to $28
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/7/7
• 评级变动
  Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/4/30
• 评级变动
  A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $28 to $35
  \u5e02\u573a\u8d44\u8baf · 2026/4/30
• A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $19 to $28
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• UBS Downgrades PROCEPT BioRobotics(PRCT.US) to Hold Rating, Cuts Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/7/3
• 评级变动
  Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  Analysts' Top Healthcare Picks: PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PRME)
  TipRanks · 2026/6/23
• 评级变动
  Morgan Stanley Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $51
  \u5e02\u573a\u8d44\u8baf · 2026/3/11
• BTIG Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/1
• 评级变动
  TD Cowen Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• 评级变动
  William Blair Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/23

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。